Senate Hearing On Ozempic, Wegovy Again Highlights Concerns About PBMs
Executive Summary
Senate HELP Committee chair Sanders is trying to broker a deal between Novo Nordisk and the major pharmacy benefit managers that will lead to lower list prices for Ozempic and Wegovy. Prominent Republican raises international reference pricing.